IDIX
Idenix Pharmaceuticals Inc
Biopharmaceutical company developing antiviral treatments
CUSIP: 45166R204HealthcareUS1 holder
Total Value
$220.73M
Total Shares
36.91M
Net Share Change
+7.25M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$220.73M36.91M shares
ADD+7.25M(+24.4%)